Join
Live feed
·
INSIDERFilingvia Quantisnow
Ultragenyx Pharmaceutical Inc. logo

EVP and Chief Medical Officer Crombez Eric was granted 31,784 shares and sold $376,584 worth of shares (8,945 units at $42.10), increasing direct ownership by 49% to 71,922 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track RARE (Ultragenyx Pharmaceutical Inc.) and more on Quantisnow.